β-Amyloid-induced coronary artery vasoactivity and endothelial damage

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 4, 1997, Pages 517-522

  Thomas, Tom ^a,b   Truitt Sutton, E ^a   Hellermann, Alison ^a   Price, Joel M ^a  

^a Department of Psychiatry ^*  (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Free radicals; Resistance vessel; Vasodilation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; AMYLOID BETA PROTEIN; ANTIOXIDANT; SUPEROXIDE DISMUTASE; THROMBOXANE A2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY CONSTRICTION; CORONARY VASCULAR RESISTANCE; DOWN SYNDROME; ELECTRON MICROSCOPY; ENDOTHELIUM LESION; HYPOTHESIS; MYOGRAPHY; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SENILE PLAQUE; VASCULAR AMYLOIDOSIS;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; AGING; AMYLOID BETA-PROTEIN; ANIMALS; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; MICROSCOPY, ELECTRON; RATS; SUPEROXIDE DISMUTASE;

EID: 0030724476     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199710000-00017     Document Type: Article

References (35)

1. Selkoe DJ. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Antut Rev Cell Biol 1994; 10: 373-403.
2. Tomlinson BE. Aging and the dementias. In: Adams JH, Duchen LW, eds. Greenftelds neitropathology. New York: Oxford University Press, 1992:1141-500.
3. Teller JK, Russo C, De Busk LM, et al. Presence of soluble amyloid β-peptide precedes amyloid plaque formation in Down's syndrome. Nature Med 1996;2:93-5.
4. Yamada T, Sasaki H, Furuya H, Myata T, Goto I, Sakaki Y. Complementary DNA for the mouse homolog of human amyloid beta protein precursor. Biochem Biophys Res Commun 1987:149:665-71.
5. Podlisny MB, Tolan DR, Selkoe DJ. Homology of the amyloid beta protein precursor in monkey and human supports of a primate model for beta amyloidosis in Alzheimer's disease. Am J Pathol 1991;138:1423-35.
6. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele e4 with late onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72.
7. Strittmatter \VJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer's disease. Proc Nat! AcadSciUSA 1993;90:1977-81.
8. Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosd 1991:135:235-8.
9. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988:8:1-21.
10. Kosunen OS, Talasniemi S, Lehtovirta M, et al. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke 1995;26:743-8.
11. Greene LA. Tischer AS. Establishment of noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. ProcNallAcadSei USA 1976;73:2424-8.
12. Wisniewski H, Weigel MJ, Wang KC, Lach B. Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neiiropathol 1992;84:117-27.
13. Hensley K, Carney JM, Mattson MP, et al. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc Nail Acad Sci USA 1994;91:3270-4.
14. Starr JM, Whalley J, Inch S, Shering A. Blood pressure and cognitive function in healthy old people. JAm GeriatrSoc 1993;41:753-6.
15. Launer LJ, Masaki K, Petrouitch H, Foley D, Haulik RJ. The association between midlife blood pressure levels and late-life cognitive function. JAMA 1995;274:1846-51.
16. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 1996;380:168-71.
17. Cabell F, Weiss DS, Price JM. Inhibition of adenosine induced coronary vasodilation by block of large-conductance calcium activated K+ channels. Am J Pliysiol 1994;267:H 1455-60.
18. + channels. Life Sci 1996:58:2225-32.
19. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid β-protein toxicity. Cell 1994:77:817-27.
20. Halliwell B, Guteridge JMC. Free radicals in biology and medicine. Oxford: Oxford University Press, 1989.
21. Mattson MP. Untangling the pathophysiochemistry of β-amyloid. Nat Struct Biol 1995;2:926-8.
22. Lipton SA, Choi YB, Pan Z-H, et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso compounds. Nature 1993;364:626-32.
23. Stamler JS. Alzheimer's disease: a radical vascular connection. Nature 1996;380:108-11.
24. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc NatlAcad Sci USA 1986;86:3375-8.
25. Vallance P, Collier J, Moncada S. Effect of endothelium derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;2: 997-1000.
26. Linder L, Kiowski W, Bühler FR, LüscherTF. Indirect evidence for the release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation 1990;81:1762-7.
27. Luscher TF, Dohi Y. Endothelium-derived relaxing factor and endothelin in hypertension. News Pliysiol Sci 1992;7:120-3.
28. Dohi Y, Thiel MA, Bühler FR, Lüscher TF. Activation of the endothelial L-arginine pathway in resistance arteries: effect of age and hypertension. Hypertension 1990;16:170-9.
29. Lüscher TF, Vanhoutte PM. The endothelium: modulator of cardiovascular function. Boca Raton, FL: CRC, 1990.
30. Van Swieten JC, Geyskes GG, Derix MM, et al. Hypertension in the elderly is associated with white matter lesion and cognitive decline. Ann Neural 1991:30:825-30.
31. Macmahon SR, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease, Part 1 : prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
32. Erkinjuntti T, Hachinski V. Rethinking vascular dementia. CerebrovascDls 1993;3:3-15.
33. Olichney JM, Hansen LA, Hofstetter CR, Grandman M, Katzman R, Thal LJ. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neural 1995;52:702-8.
34. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-9.
35. Fletcher JG, Carlson W, Lilly LS. Acute myocardial infarction. In: Lilly LS, ed. Pathophysiology of heart disease. Malvern, PA: Lea &Febiger, 1993:113-6.